- Home
- DV vs HRMY Comparison
DV vs HRMY Comparison
Compare DV & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DV
- HRMY
- Stock Information
- Founded
- DV 2008
- HRMY 2017
- Country
- DV United States
- HRMY United States
- Employees
- DV N/A
- HRMY N/A
- Industry
- DV Computer Software: Prepackaged Software
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- DV Technology
- HRMY Health Care
- Exchange
- DV Nasdaq
- HRMY Nasdaq
- Market Cap
- DV 2.4B
- HRMY 2.0B
- IPO Year
- DV 2021
- HRMY 2020
- Fundamental
- Price
- DV $15.41
- HRMY $32.16
- Analyst Decision
- DV Buy
- HRMY Strong Buy
- Analyst Count
- DV 18
- HRMY 9
- Target Price
- DV $18.92
- HRMY $54.22
- AVG Volume (30 Days)
- DV 3.0M
- HRMY 609.1K
- Earning Date
- DV 07-29-2025
- HRMY 08-05-2025
- Dividend Yield
- DV N/A
- HRMY N/A
- EPS Growth
- DV N/A
- HRMY 13.13
- EPS
- DV 0.29
- HRMY 2.62
- Revenue
- DV $681,128,000.00
- HRMY $744,852,000.00
- Revenue This Year
- DV $15.65
- HRMY $20.10
- Revenue Next Year
- DV $11.67
- HRMY $18.01
- P/E Ratio
- DV $52.70
- HRMY $12.27
- Revenue Growth
- DV 15.30
- HRMY 20.62
- 52 Week Low
- DV $11.52
- HRMY $26.47
- 52 Week High
- DV $23.11
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- DV 65.25
- HRMY 43.25
- Support Level
- DV $14.87
- HRMY $31.70
- Resistance Level
- DV $15.32
- HRMY $33.69
- Average True Range (ATR)
- DV 0.38
- HRMY 0.89
- MACD
- DV 0.05
- HRMY -0.10
- Stochastic Oscillator
- DV 93.52
- HRMY 37.30
About DV DoubleVerify Holdings Inc.
DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.